Hoorah for herbal
PerkinElmer has announced that its technology can be used to ensure the safety of traditional Chinese herbal medicines.
PerkinElmer has announced that its technology can be used to ensure the safety of traditional Chinese herbal medicines. In a recent collaboration with the Chinese food and drug institute the company has shown that its inductively coupled plasma mass spectrometer (ICP-MS) technology can be used to monitor the inorganic impurities within these remedies. This collaboration came about amid concerns that herbal ingredients may contain potentially toxic contaminants.
Traditional Chinese herbal medicines (TCHMs) have been used for many years but in recent times have been modernized by transforming the plants and ingredients to solutions, soluble granules and tablets. These types of medicines are used worldwide and as such are grown in varying types of soils and conditions, which means that there are biological variations giving rise to the need for safety, efficacy and quality evaluations.
From 1 July 2010, the Chinese Pharmacopoeia 2010 (CP) will take effect with an important update setting out limitations on five elements (Cu, As, Cd, Hg and Pb) for all venous herbal injections and some medicinal plants. In an application note available from the company, the ELAN ICP-MS instruments were used for the routine quantification of inorganic impurities in TCHM. It was demonstrated that the instruments were capable of establishing method detection limits for the five elements that were low enough to analyse and evaluate samples of TCHM so that the requirements of the CP were met.
More information on the products mentioned in this story or a copy of the application note are available from PerkinElmer’s website at www.perkinelmer.com
This story originally appeared in The Column. Click here to view that issue.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
Katelynn Perrault Uptmor Receives the 2025 LCGC Emerging Leader in Chromatography Award
Published: November 13th 2024 | Updated: November 13th 2024November 13, 2024 – LCGC International magazine has named Katelynn A. Perrault Uptmor, Assistant Professor of Chemistry at the College of William & Mary, the recipient of the 2025 Emerging Leader in Chromatography Award. This accolade, which highlights exceptional achievements by early-career scientists, celebrates Perrault Uptmor’s pioneering work in chromatography, particularly in the fields of forensic science, odor analysis, and complex volatile organic compounds (VOCs) research.
